Skip to content
Screener

Book value per share at other companies

Semtech logo
SemtechSMTC
$5.85-7.9%
AutoZone logo
AutoZoneAZO
-$165.24+28.5%
Synopsys logo
SynopsysSNPS
$158.62+150%
Cisco Systems, Inc. logo
Cisco Systems, Inc.CSCO
$12.27+6.9%
Nucor logo
NucorNUE
$93.56+8.6%
Northern Trust logo
Northern TrustNTRS
$69.62+6.0%

Other financials

Income statement

See full
Operating income-$26.1M-62.4%
Net income-$24.2M-97.8%
EPS (diluted)-$0.80+93.8%

Balance sheet

See full
Cash & equivalents$237.4M
Total debt$1.0M
Total equity$454.3M+421%
Total assets$467.8M

Cash flow

See full
Operating cash flow-$22.6M-47.6%
CapEx$23.0K
Free cash flow-$22.7M-47.8%

Valuation

See full
Market cap$2.32B+107%
Enterprise value$2.08B

Returns & leverage

See full
Return on equity-45.7%
Debt / equity
Current ratio35.8×

Where this comes from

Calculated from Hemab Therapeutics Holdings, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Hemab Therapeutics Holdings, Inc.’s 10-Q, filed August 11, 2026. Open the filing →

Filed
Aug 11, 2026, 4:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-344533

FAQ

What is Hemab Therapeutics Holdings, Inc.'s book value per share?
Hemab Therapeutics Holdings, Inc. (COAG) reported book value per share of $15.09 in Q2 2026.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about Hemab Therapeutics Holdings, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude